Medical policy

Displaying 1 - 10 of 99

SPRAVATO® (esketamine) nasal spray CIII place of service (POS) requirements

View our latest article on SPRAVATO® (esketamine) nasal spray - used to treat treatment-resistant depression in adults - and its documentation requirements.

SPRAVATO® (esketamine) nasal spray CIII place of service (POS) requirements

View our latest article on SPRAVATO® (esketamine) nasal spray - used to treat treatment-resistant depression in adults - and its documentation requirements.

Update history: LCD and article updates

View the most recent updates for our LCDs and articles. An LCD and two articles have been revised.

Update history: LCD and article updates

View the most recent updates for our LCDs and articles. An LCD and two articles have been revised.

View NCDs

CMS develops NCDs to describe circumstances for Medicare coverage nationwide for an item or service. NCDs generally outline the conditions for which an item or service is covered (or not covered)…

View NCDs

CMS develops NCDs to describe circumstances for Medicare coverage nationwide for an item or service. NCDs generally outline the conditions for which an item or service is covered (or not covered)…

Independent diagnostic testing facility (IDTF) quick reference

IDTFs are required to report the exact CPT/HCPCS codes and procedures they intend to perform when enrolling with the CMS-855B form.

Open meeting minutes

View materials and listen to recordings from past meetings.

Open meeting minutes

View materials and listen to recordings from past meetings.

Contractor advisory committee (CAC) meeting minutes

View CAC meeting minutes from our meeting on February 19, 2026, on the use of urine-based biomarkers in patients with microhematuria.